Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia

Persistent fetal gene expression in pediatric malignancies is considered a consequence of prenatal maturation blockade. In this study, we demonstrate that oncogenic PTPN11 mutations enhance cellular plasticity. This leads to partial restoration of fetal molecular programs, creating new therapeutically exploitable vulnerabilities. See related commentary by Miao and Xu, pp. 168.

Authors

Institutions

Publication Details

Journal
Blood Cancer Discovery
Published
2025-12-05
DOI
https://doi.org/10.1158/2643-3230.bcd-25-0246
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia

Pavlo Lutsik, Kai Tan, Katharina Bauer, Stefan Fröhling et al.
Blood Cancer Discovery
Acute Myeloid Leukemia Research
article

Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia

Pavlo Lutsik, Kai Tan, Katharina Bauer, Stefan Fröhling, Marc Jan Bonder, Christian Flotho, Miriam Erlacher, Mark Hartmann, Daniel B. Lipka, Christoph Plass, Viktoria Flore, Christian Buske, Maximilian Schönung, Elliot Stieglitz, Simon Haas, Sina Stäble, Fatemeh Alikarami‬, Jens Langstein, Eleonora Khabirova, Dirk Lebrecht, Changya Chen, Joschka Hey, Valentin Maurer, Abdul‐Habib Maag, Mariam Hakobyan, Jan‐Philipp Mallm, Muzlifah A. Haniffa, Sam Behjati, Michael D. Milsom, Roland Roelz, Matthias Schlesner, Dominik Vonficht, Tobias Boch, Laura Jardine, Simon Raffel, Kathrin M. Bernt, Sheila Bohler, Ling Hai, Jun Wang, Julia Meyer, Charlotte M. Niemeyer, Jovana Rajak
article en

Abstract

Persistent fetal gene expression in pediatric malignancies is considered a consequence of prenatal maturation blockade. In this study, we demonstrate that oncogenic PTPN11 mutations enhance cellular plasticity. This leads to partial restoration of fetal molecular programs, creating new therapeutically exploitable vulnerabilities. See related commentary by Miao and Xu, pp. 168.

Blood Cancer DiscoveryVol. 7(2)
Helmholtz Association of German Research Centres (DE), Children's Hospital of Philadelphia (US), University of Freiburg (DE), Queen Mary University of London (GB), University of Augsburg (DE), German Cancer Research Center (DE), University of California, San Francisco (US), Universität Ulm (DE), Max Delbrück Center (DE), Heidelberg University (DE), University of Cambridge (GB), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), Cambridge University Hospitals NHS Foundation Trust (GB), Wellcome Sanger Institute (GB), Bridge University (SS), National Center for Tumor Diseases (DE), Institute of Human Genetics (PL), UCSF Benioff Children's Hospital (US), European Molecular Biology Laboratory (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), AstraZeneca (Canada) (CA), DKFZ-ZMBH Alliance (DE), Heidelberg Institute for Stem Cell Technology and Experimental Medicine (DE), European Molecular Biology Laboratory (DE), University Hospital Ulm (DE), University Medical Centre Mannheim (DE), Centre for Structural Systems Biology (DE), Medizinische Fakultät Mannheim, Charité - Universitätsmedizin Berlin (DE), University of Pennsylvania (US), Newcastle University (GB), Epigenomics (Germany) (DE), Otto-von-Guericke-Universität Magdeburg (DE), KU Leuven (BE)
Openalex Percentile: Top 42%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.